The accreditors of this session require that you periodically check in to verify that you are still attentive.
Please click the button below to indicate that you are.
Discover why reliance on a small subset of “super donors” could introduce risk and ignite ethical considerations for cell and gene therapy companies seeking sustainable growth and scalability.
Learning Objectives:
Describe how known and unknown inherent differences in human beings and populations can impact starting material
Describe how access to a large pool of diverse donors is essential for current and future needs
Discover how the use/overuse of “super donors” involves not only technical, regulatory and medical issues, but also ethical and legal issues
Discuss strategic solutions for sustainable cell and gene therapy development and growth